Treatment of glioblastoma multiforme in the elderly in functionally non-critical areas. Clinical remarks on 22 patients

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 3, 2003, Pages 395-398

  Salvati, M ^a,c   Piccirilli, M ^b   Caroli, E ^b   Brogna, C ^b   Artizzu, S ^b   Frati, A ^a  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NONE   (Italy)

Author keywords

Chemotherapy; Elderly Cancer Patients; Glioblastoma Multiforme; Multimodality treatment; Radiotherapy; Surgery

Indexed keywords

TEMOZOLOMIDE;

AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GLIOBLASTOMA; HUMAN; LENGTH OF STAY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; SURVIVAL RATE;

EID: 0141782312     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kleihues P., Burger P.C., Collins V.P., Newcomb E.W., Ohgaki H., Cavenee W.K.: Glioblastoma. In: Kleihues P., Cavenne W.K., eds. Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press 2000: 29-39.
2. Brandes A.A., Fiorentino M.: The role of chemotherapy in recurrent malignant gliomas: an overview. Cancer Invest. 14: 547-555, 1996.
3. Greig N.H., Ries L.G., Yancik R., Rapoport S.I.: Increasing annual incidence of primary malignant brain tumors in the elderly. J. Natl. Cancer Inst. 82: 1621-1624, 1990.
4. Wemer M.H., Phuphanich S., Lyman G.H.: The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer 76: 1634-1642, 1995.
5. Fleury A., Menegoz F., Grosclaude P., Daures J.P., Henry-Amar M., Raverdy N., Schaffer P., Poisson M., Delattre J.Y.: Descriptive epidemiology of cerebral gliomas in France. Cancer 79: 1195-1202, 1997.
6. O'Reilly S., Newlands E., Brown G.: Investigation of human in vivo tissue and tumor pharmacokinetics and mechanism of action of temozolomide. Br. J. Cancer 69 (suppl 2):23, 1994.
7. Chandler K.L., Prados M.D., Malec M., Wilson C.W.: Long term survival in patients with glioblastoma multiforme. Neurosurgery 32:716-720, 1993.
8. Sneed P.K., Prados M.D., McDermott M.W., Larson D.A., Malek M.K., Lamborn K.R., Davis R.L., Weaver K.A., Wara W.M., Philips T.L., Gutin P.H.: Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachitherapy boost. Neurosurgery 36:898-903, 1995.
9. Ampil F., Fowler M., Kim K.: Intracranial astrocytoma in elderly patients. J. Neurooncol. 12(2):125-130, 1992.
10. Tomita T., Raimondi A.J.: Brain tumors and the elderly. JAMA 246:53-55, 1981.
11. Brandes A.A., Fiorentino M.: Treatment of high grade gliomas in the elderly. Oncology 55:1-6, 1998.
12. Barker F.G. II, Prados M.D., Chang S.M., Davis R.L., Gutin P.H., Lamborn K.R., Larson D.A., McDermott M.W., Sneed P.K., Wilson C.B.: Bromodeoxyuridine labelling index in glioblastoma multiforme: Relation to radiation response, age, and survival. Int. J. Radiat. Oncol. Biol. Phys. 34:803-808, 1996.
13. Rosemblum M.L., Gerosa M., Dougherty D.V., Reese C., Barger G.R., Davis R.L., Levin V.A., Wilson C.B.: Age related chemosensitivity of stem cells from human malignant brain tumors. Lancet 1:885-887, 1982.
14. Rajan B., Ross G., Lim C.C., Ashkey S., Goode D., Traish D., Brada M.: Survival in patients with recurrent glioma as a measure of treatment efficacy: Prognostic factors following nitrosurea chemotherapy. Eur. J. Cancer 30A: 1809-1815, 1994.
15. Grant R., Liang B.C., Page M.A., Cranme D.L., Greenberg H.S., Junck L.: Age influences chemotherapy response in astrocytomas. Neurology 45:929-933, 1995.
16. Iwadate Y., Fujimoto S., Tagawa M., Namba H., Sueyoshi K, Hirose M., Sakiyama S.: Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas. Int. J. Cancer 69:236-240, 1996.
17. Yount G.L., Haas-Kogan D.A., Vidair C.A., Haas M., Dewey W.C., Israel M.A.: Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Cancer Res. 56:500-506, 1996.
18. Louis D.N.: The p53 gene and protein in human brain tumors. J. Neuropathol. Exp. Neurol. 53:11-21, 1994.
19. Peschel R.E., Wilson L., Haffty B., Papadopoulos D., Rosenzweig K., Feltes M.: The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III-IV gliomas. Int. J. Radiation Oncology Biol. Phys. 26:539-544, 1993.
20. Meckling S., Dold O., Forsyth P.A.J., Brasher P., Hagen N.A.: Malignant supratentorial glioma in the elderly: is radiotherapy useful? Neurology 47:901-905, 1996.
21. Villà S., Vinolas N., Verger E., Yaya R., Martinez A., Gil M., Moreno V., Caral L., Graus F.: Efficacy of radiotherapy for malignant gliomas in elderly patients. Int. J. Radiation Oncology Biol. Phys. 42:977-980, 1998.
22. Leenstra S., Bijlsma E.K., Troost D., Oosting J., Westerveld A., Bosch D.A., Hulsebos T.J.M.: Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis. Br. J. Cancer 70:684-689, 1994.
23. Barker F.G. II, Chang S., Larson D.A., Sneed P.K., Wara W.M., Wilson C.B., Prados M.D.: Age and radiation response in glioblastoma multiforme. Neurosurgery 49: 1288-1299, 2001.
24. Lacroix M., Abi-Said D., Fourney D.R., Gokaslan Z.L., Shi W., DeMonte F., Lang F.F., McCutcheon I.E., Hassenbusch S.J., Holland E., Hess K., Michael C., Miller D., Samaya R.: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J. Neurosurg. 95:190-198, 2001.